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Summary MZ co-twins is smaller than that between DZ co-twins
(Smith et al. 1973; Moller et al. 1978; Dequeker et al.The purpose of this paper is to report the linkage of a
1987; Pocock et al. 1991; Slemenda et al. 1991; Younggenetic locus (designated ‘‘HBM’’) in the human genome
et al. 1995). It has been estimated that as much as 60%to a phenotype of very high spinal bone density, using
of the variance in skeletal mass is inherited (Smith et al.a single extended pedigree. We measured spinal bone-
1973; Slemenda et al. 1991; Krall and Dawson-Hughesmineral density, spinal Z(BMD), and collected blood
1993). In addition, peak skeletal mass is the best measur-from 22 members of this kindred. DNA was genotyped
able determinant of fracture risk in the elderly (Hui eton an Applied Biosystems model 377 (ABI PRISM Link-
al. 1989), although bone loss during later adult life isage Mapping Sets; Perkin Elmer Applied Biosystems),
also a factor (Hui et al. 1990; Johnston and Longcopeby use of ﬂuorescence-based marker sets that included
1990; Chesnut 1991). Thus, study of the genetic basis345 markers. Both two-point and multipoint linkage
of osteoporotic fracture can be approached throughanalyses were performed, by use of affected/unaffected
study of the molecular-genetic determination of peakand quantitative-trait models. Spinal Z(BMD) for af-
bone mass.fected individuals (N Å 12) of the kindred was 5.54
Past research to identify speciﬁc genes that inﬂuence{ 1.40; and for unaffected individuals (N Å 16) it was
peak bone mass has focused mainly on candidate genes0.41 { 0.81. The trait was present in affected individu-
with identiﬁable polymorphisms. For example, the vita-als 18–86 years of age, suggesting that HBM inﬂuences
min D–receptor (VDR) locus has been associated withpeak bone mass. The only region of linkage was to a
spinal and femoral bone mass (Morrison et al. 1994;series of markers on chromosome 11 (11q12-13). The
Howard et al. 1995; Riggs et al. 1995; Spector et al.highest LOD score (5.21) obtained in two-point analy-
1995). However, studies of genetic control of bone masssis, when a quantitative-trait model was used, was at
are challenging, because bone mass is a polygenic, con-D11S987. Multipoint analysis using a quantitative-trait
tinuous trait, confounded by nongenetic (environmen-model conﬁrmed the linkage, with a LOD score of 5.74
tal) factors that include (among others) hormone status,near marker D11S987. HBM demonstrates the utility
nutrition, age, physical activity, and comorbid diseaseof spinal Z(BMD) as a quantitative bone phenotype that
(Matkovic et al. 1979; Richelson et al. 1984; Dequekercan be used for linkage analysis. Osteoporosis pseu-
and Guesens 1985; Kanders et al. 1987; Nilas and Chris-doglioma syndrome also has been mapped to this region
tiansen 1987). Furthermore, each skeletal anatomic siteof chromosome 11. Identiﬁcation of the causal gene for
may be inﬂuenced by several genes that themselves differboth traits will be required for determination of whether
from site to site. Conclusions about inherited traits,a single gene with different alleles that determine a wide
range of peak bone densities exists in this region. reached from numerous reports on groups of unrelated
persons, are likely to be confounded by problems such
as genetic heterogeneity, variable allele frequencies, and
Introduction variable gene penetrance. These problems may prove
difﬁcult to overcome in association studies, even withPeak mass of the adult skeleton is under genetic control.
large sample sizes. It is thus not surprising that, whenTwin studies show that the bone-mass variance between
viewed as a group, the results of past VDR–bone-mass
studies have been inconsistent, despite the inclusion ofReceived September 25, 1996; accepted for publication March 16,
some studies of twins (Hustmyer et al. 1994; Morrison1997.
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Family-based-study designs that use linkage analysis GENESCANTM 672 and GENOTYPERTM software for
allele identiﬁcation. These marker sets have been opti-(e.g., sib-pair or pedigree studies) are generally more
informative than association studies. The limited genetic mized for this hardware/software and are intended to
be used in a multiplex format to facilitate rapid genotyp-heterogeneity within families, combined with detailed
knowledge of the pedigree, is a key factor. Furthermore, ing of large numbers of DNA samples. This linkage-
marker set contains 345 markers that cover the humangenetic-linkage studies work best when the phenotype
under study is discrete. The purpose of this paper is to genome, excluding the X and Y chromosomes, at a spac-
ing interval of 7–22 cM. The spacing of these markersreport the linkage of a genetic locus in the human ge-
nome to very high bone mass (HBM), by use of a single is such that õ2% of the genome lies ú10 cM from a
marker and Ç50% lies õ5 cM from a marker.extended pedigree. Follow-up studies may include an
investigation of the genetic basis of a mechanism that PCR reactions were performed in two fashions. All
reagents were purchased from Perkin Elmer–Appliedregulates peak bone mass.
Biosystems. We performed individual PCR reactions
with the markers from the Linkage Mapping Panels 12,Material and Methods
13, and 15–18, exactly as described by the supplier,
The study was approved by the Creighton University using AmpliTaq DNA polymerase. All other panels were
Institutional Review Board. Each subject signed an in- performed in a multiplex fashion. Markers from each
formed-consent document prior to participating in the panel were multiplexed in the PCR reaction, on the basis
project. of color (dye label). Thus, for each DNA sample, only
three reactions (one blue-, one green-, and one yellow-
A. Bone-Mass Measurements labeled group of markers) were performed with each
Bone-mineral density (BMD; g/cm2) measurements of panel. The multiplex PCR reactions were performed in
the spine (L1–L4), hip, and total body, performed in a 50-ml reaction volume with the following ﬁnal concen-
Omaha, were done by dual energy x-ray absorptiometry trations: 1 1 PCR Buffer II, 2.5 mM MgCl2, 10 pmol
(DXA; Hologic 2000). Measurement of BMD obtained of each primer, 250 ng of DNA, and 3 units of AmpliTaq
at other centers used the available DXA equipment (Ho- Gold DNA Polymerase. Thermal cycling was done by
logic or Lunar DPX). Absolute values for spinal BMD use of a Perkin Elmer 9600 thermal cycler. Conditions
were normalized to that of age- and sex-matched indi- were 95C for 5 min, followed by 30 cycles of 95C for
viduals from the normal database obtained on each 1 min, 60C for 1 min, 72C for 1 min and then followed
manufacturer’s equipment, to enable calculation of spi- by a 30-min extension at 60C. After cycling, the reac-
nal Z(BMD) for each person. Spinal Z(BMD) for an tions were cooled to 4C until removal from the thermal
individual is the quantitative phenotype used in the link- cycler. The three separate multiplex reactions were
age analysis. It is deﬁned as the number of SDs above pooled at the following ratios: 5 ml each of the blue
or below the mean of normal age- and sex-matched (Fam-labeled) markers and green (Tet-labeled) markers,
persons. Spinal Z(BMD) was obtained in every case; hip 10 ml of the yellow (Hex-labeled) markers, and 20 ml of
(N Å 13) and total body (N Å 7) measurements were deionized water. Pooled reactions were stored at 020C
made when possible. In addition, we obtained a com- until gel electrophoresis.
plete clinical history and forearm radiograph in all cases. A portion (1.5 ml) of the pooled reaction was added
An extensive radiographic skeletal survey was per- to 3.5 ml of loading buffer containing deionized for-
formed on the proband and her mother. mamide, blue dextran, and TAMRA 350 size standards
(Perkin Elmer–Applied Biosystems). After being heated
B. Genotyping at 95C for 5 min to denature the DNA, the samples
were loaded and electrophoresed as described in the op-Blood (20 ml) was drawn into lavender-cap (EDTA-
containing) tubes by a certiﬁed phlebotomist and was erator’s manual for the model 377 DNA sequencer.
After gel electrophoresis, the data were analyzed bystored refrigerated until DNA extraction. DNA extrac-
tion was done with a kit (Gentra Systems), according to use of GENESCAN and GENOTYPER software. Be-
fore the ﬁrst analysis step, within the GENESCAN soft-the manufacturer’s directions. The yield of DNA was
routinely ú40 mg of whole blood/ml, with a molecular ware, the lane tracking was optimized manually. After
the gel-lane data were extracted, the standard curveweight of ú50 kb. DNA was archived by storing coded
50-mg aliquots at 080C as an ethanol precipitate. proﬁles of each lane were examined and veriﬁed for
linearity and size calling. Lanes with problems for ei-DNA was genotyped by use of the ﬂuorescence-based
marker sets (Reed et al. 1994) commercially available ther of these parameters were retracked and veriﬁed.
Once all lanes had been tracked and the size standardsthrough Perkin Elmer Applied Biosystems (ABI PRISM
Linkage Mapping Sets) on an Applied Biosystems auto- had been identiﬁed correctly, the data were imported
into GENOTYPER for allele identiﬁcation. To expeditemated DNA sequencing system (model 377) running the
/ 9a2a$$ju28 05-15-97 17:21:15 ajhga UC-AJHG
1328 Am. J. Hum. Genet. 60:1326–1332, 1997
Table 1allele identiﬁcation, we obtained the program Linkage
Designer from the Internet website of Dr. Guy Van
Anthropomorphic and DXA Characteristics of Proband and
Camp (http://alt-www.uia.ac.be/u/dnalab/ld.html; Van Immediate Family
Camp et al., in press). This program facilitated impor-
Age Height Weight Spinal BMD Spinaltation of data generated by GENOTYPER, into the
(years) (cm) (kg) (g/cm2) Z(BMD)pedigree-drawing program Cyrillic (version 2.0; Cher-
well Scientiﬁc Publishing).
Proband 18 167.5 58.0 1.667 5.63
Mother 51 165.0 63.4 1.500 4.98C. Linkage Analysis Father 52 183.0 84.7 1.118 .25
Pedigree/marker data were exported from Cyrillic into Brother 15 167.6 61.7 1.022 .45
the Makeped program and were converted to a ﬁle suit-
able for linkage analysis. Two-point and multipoint
linkage analysis were performed by use of the MLINK
and LINKMAP components of LINKAGE (Lathrop et of back pain precipitated by an auto accident. She suf-
al. 1985). Recombination fraction (uˆ) and maximum fered soft-tissue injury to her lower back, manifested as
LOD score (Zmax) were calculated by use of the ILINK pain and muscle tenderness. There was no radiographic
subroutine. evidence of fracture or subluxation. At the time of pre-
We used three different models to analyze for linkage: sentation, she had nearly recovered from the injury and,
two affected-trait models, one with full penetrance and except for vigorous recreational and varsity sports, had
one with partial penetrance (.9); and a quantitative-trait resumed the usual activities of a high-school student.
model. For the affected-trait models, the following crite- Physical exam revealed a normal healthy young woman.
ria were applied for selection of affected individuals: (1) Radiographs of the entire skeleton revealed dense bones
spinal Z(BMD) ú 3.0, (2) a clinical history without with thick cortices. All bones of the skeleton were dense
evidence of any knownHBM syndrome, and (3) forearm and of normal shape. There were no skeletal radio-
radiographs showing a normal shape of the appendicu- graphic lesions characteristic of any of the known condi-
lar skeleton. For the quantitative-trait analysis, we de- tions associated with HBM, in either the proband or her
ﬁned NN as a mean spinal Z(BMD) of 0.41; ND as a mother.
mean spinal Z(BMD) of 5.54 and DD as a mean spinal The radiographic ﬁndings and the data in table 1 sug-
Z(BMD) of 10.67, where N represents the normal allele gested that the proband had inherited from her mother
and D represents the disease allele. The mean of the NN a trait that resulted in very dense bones but an otherwise
individuals was calculated from the spinal Z(BMD) of normal skeleton. Therefore, we focused further studies
the unaffected individuals within the family (with indi- on the maternal kindred.
vidual 16 being excluded; see Discussion). Since the phe-
Studies of Maternal Kindrednotype is very rare in the general population, we inferred
that the allele frequency for the HBM-gene mutation The kindred was of mixed Caucasian (European) de-
conferring HBM is extremely low. We thus assumed scent. The portion of the kindred used for the whole-
that affected individuals were heterozygotes, and we cal- genome screening and linkage analysis is shown in ﬁgure
culated the mean for ND from the affected individuals 1. The deceased maternal grandfather of the proband
in the family. We assumed an additive model to estimate was phenotyped through medical records and antemor-
the mean for DD individuals, on the basis of the differ- tem skeletal radiographs. The phenotype of other de-
ence, in means, between the NN group and the ND ceased members was inferred from the pattern of inheri-
group. The variance for the unaffected individuals (ex- tance, to expedite linkage analysis. The pattern of
cluding Individual 16) was 0.66, and that for the af- inheritance of the HBM trait in this family is autosomal
fected individuals was 1.96. In all three models, we as- dominant. X linkage is ruled out by the presence of
sumed equal frequencies for each allele of a marker, male-to-male transmission from individual 12 to indi-
since population-based frequencies were not available viduals 14 and 15. Twenty-two informative individuals
for all markers. completed both phenotyping and genotyping for the
linkage analysis. In all, 28 individuals were phenotyped
by DXA. Spinal Z(BMD) in the affected (N Å 12) groupResults
was 5.54 { 1.40; and that in the unaffected (N Å 16)
Phenotype Inheritance and Description group was 0.41 { 0.81, indistinguishable from that in
normal members of the population.The proband was referred, by her physicians, to the
Creighton Osteoporosis Research Center, for evaluation Hemograms, standard serum clinical chemistry, and
bone-marker measurements (alkaline phosphatase,of ‘‘unusually dense bones.’’ She was 18 years old and
had come to medical attention 2 years earlier because bone-speciﬁc alkaline phosphatase, osteocalcin, pyridi-
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Figure 1 Pedigree of HBM family. Under each individual is an ID number, the spinal Z(BMD), and the allele identiﬁcation for markers
D11S935, D11S905, D11S1513, D11S987, D11S1314, and D11S937. Blackened symbols represent either affected individuals or, in cases
where phenotype was not available, those presumed to be affected; and symbols containing ‘‘N’’ represent unaffected individuals. Genotypes
within parentheses are inferred.
noline cross-links, and deoxypyridinoline cross-links) Linkage Analysis
were performed on a subset of ﬁve affected individuals, On the basis of the bimodal distribution of spinal
revealing no abnormalities. DXA measurements for the Z(BMD) (ﬁg. 2), we ﬁrst performed two-point linkage
hip and total body were congruent with the results from analysis using a simple affected (spinal Z[BMD] ú 3.0),
spinal Z(BMD). None of the affected individuals were autosomal dominant model with full penetrance, to
aware of the presence of an unusual degree of HBM.
None had clear-cut clinical, historical, radiographic, or
laboratory ﬁndings that could be associated with HBM
or that would point to one of the known syndromes of
high bone density. No affected member of the kindred
reported a history of any type of bone fracture. The
HBM trait did not seem to affect the health or well-
being of the affected individuals.
Genotyping
We performed the genome screening by using the 345
markers of the autosomal Perkin Elmer–Applied Biosys-
tems Linkage Mapping Panels. The ﬁrst-attempt success
rate for markers used with individual PCR was 94%
(73/78), whereas that for markers used with multiplex
Figure 2 Spinal Z(BMD) of all kindred members contributingPCR was 92% (245/267). A listing of markers suffering
to this analysis. Affected females (F Yes), unaffected females (F No),from ﬁrst-attempt failure is available on request. The
affected males (M Yes), and unaffected males (M No) are represented
advantage of the multiplex PCR is the estimated 10- as unblackened squares. The HBM trait appears at least by the time
fold increase in speed with which the panel sets can be of skeletal maturity and persists throughout the remainder of the life
span.analyzed.
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Table 2 haplotype was the same as that of the ‘‘affected’’ individ-
uals. Several explanations could account for individual
Two-Point Zmax , by Model and Marker 16’s status. The most likely possibility is that our arbi-
trary threshhold for determining affected status, spinalModel and Marker uˆ Zmax
Z(BMD) ú 3.0, is too high. Among members of a nor-
Affected with full penetrance: mal population, only 1/740 have spinal Z(BMD) ú 3.0,
D11S905 .064 2.089 and only 1/458 have spinal Z(BMD) ú 2.85. This is a
D11S1313 .107 1.572
small difference. Simply reducing the threshhold to in-D11S987 .044 4.055
clude Individual 16 as affected will increase the LODD11S1314 .000 2.961
D11S937 .123 1.974 score to that of the quantitative-trait analysis, but it
Affected with partial penetrance (.9): compromises the rigor of our study in an unacceptable
D11S905 .000 2.454 manner, because of the post hoc redeﬁnition of affected
D11S1313 .000 1.932
status. A second possibility is that individual 16 hasD11S987 .000 4.474
the marker haplotype but has a double crossover in theD11S1314 .000 3.172
D11S937 .089 2.136 region between markers D11S987 and D11S1314, re-
Quantitative trait: sulting in deletion of the HBM-gene mutation that is
D11S905 .051 2.096 responsible for conferring HBM. Saturation mapping of
D11S1313 .000 2.679
the region by additional markers ultimately will addressD11S987 .000 5.207
this possibility. Inaccurate phenotyping is a third pos-D11S1314 .000 3.963
D11S937 .061 2.747 siblity, but it is excluded when a second spinal Z(BMD)
measurement was indistinguishable from the ﬁrst mea-
surement.
Of particular interest is the mapping of osteoporosis
search for a region of linkage in the genome. The only
pseudoglioma syndrome (OPS) to this region of chromo-
region of linkage was to a series of markers on chromo-
some 11 (Gong et al. 1996). OPS is an autosomal reces-
some 11 (11q12-13). We next modeled the markers on
sive trait of juvenile osteoporosis and other complica-
chromosome 11, using an affected autosomal dominant
tions, the opposite phenotype of the HBM trait. The
model with partial penetrance. Finally, we used the
localization of the HBM and OPS traits to the same
quantitative-trait model. The results of all three models
region of chromosome 11 raises several possibilities.
are shown in table 2. The multipoint map resulting from
use of the quantitative-trait model is shown in ﬁgure 3.
The Zmax (5.74) was near marker D11S987 (map posi-
tion 55 in ﬁg. 3). The 95% conﬁdence interval places the
HBM gene between D11S905 and D11S937, a region
of Ç30 cM (map position 41–71 in ﬁg. 3). Haplotype
analysis also places the HBM gene within this region
(ﬁg. 1). uˆ and Zmax for the critical markers, derived from
the two-point and multipoint linkage analyses, are
shown in table 2.
Discussion
By analyzing DNA for linked markers in 22 members
of an extended kindred, we have mapped to chromo-
some 11q12-13 a genetic locus (the HBM locus) that
determines very high bone density. The 5.74 Zmax ob-
tained in multipoint analysis was near D11S987. The
5.21 Zmax obtained in two-point analysis was at
D11S987. The 95% conﬁdence interval places the HBM
locus in an Ç30-cM region between markers D11S905
and D11S937. In this analysis, the haplotype of affected
individuals, for markers D11S1313, D11S987, and
Figure 3 Multipoint map of chromosome 11. A region nearD11S1314, appears as 7-6-4 (ﬁg. 1).
marker D11S987 gave the Zmax (i.e., 5.74). The 95% conﬁdence inter-Individual 16 (see ﬁg. 1), with spinal Z(BMD)Å 2.85, val for the location of the HBM gene is anÇ30-cM region demarcated
ﬁts our a priori deﬁnition of unaffected (see Material by the dashed lines, that is bounded by markers D11S905 and
D11S937.and Methods). However, genotyping revealed that her
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One is that the traits are caused by allelic variation of a major advance in both the understanding of pathways
that regulate bone density and the understanding of thethe same gene. The mutation for OPS would behave as a
recessive (loss-of-function) mutation, causing low bone pathogenesis of diseases such as osteoporosis.
mass. That for HBMwould behave as a dominant (gain-
of-function) mutation, causing HBM. A second possibil- Acknowledgments
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